Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT02410122
PROGSTAR-4 STUDY
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy (ProgStar-4).
Type: Observational
Status of the trial: Completed
Orphan Drug Recognition: No
Inclusion
- Opening Date: 2014-12-12
- Closing Date: 2018-03-31
Criteria
Inclusion: Participants with PROM1 mutations and associated STGD4 phenotype
Children: No
Adults: No
Funder Type: patient organisation
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
